Short Wave The history and future of mRNA vaccine technology (encore)
Nov 1, 2021
Dr. Margaret Liu, a physician and board chair of the International Society for Vaccines, shares her expertise on the revolutionary mRNA vaccine technology. She discusses its historical roots and the groundbreaking success it achieved during COVID-19 trials. The conversation dives into the unique mechanisms of mRNA vaccines, including advancements like lipid nanoparticles. Liu also explores future possibilities for mRNA applications in flu, HIV, and cancer treatments, while addressing distribution challenges that could impact global access.
AI Snips
Chapters
Transcript
Episode notes
mRNA Vaccine Mechanism
- mRNA vaccines use a piece of mRNA coding sequence to make a single protein.
- This triggers an immune response, protecting against future encounters with the real virus.
mRNA Vaccine Challenges
- mRNA's instability requires encasing it in lipid nanoparticles for protection and delivery.
- Scientists also had to fine-tune the mRNA to achieve the "Goldilocks" level of inflammation for optimal immune response.
Pre-Pandemic mRNA Research
- mRNA vaccine technology predates the pandemic but research and trials progressed slower due to limited resources and urgency.
- The pandemic accelerated development by prioritizing funding and manufacturing.